TCI GENE Inc.
6879
Rank in Stocks
#25056
TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized... TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized preventative healthcare solutions. The company offers an extensive range of genetic screenings, including tests for nutrient metabolism, weight management, and specific G2 and ACE2 markers. Its diverse product portfolio encompasses dietary supplements, skincare items, anti-aging treatments, products designed to support children's development, and solutions targeting Alzheimer's disease. Additionally, TCI GENE provides specialized serums for DNA typing and offers professional nutrition counseling services.
Share Price
$1.08
Last synced: 2026-11-10
Market Cap
$28.63M
Change (1 day)
-0.70%
Change (1 year)
-16.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TCI GENE Inc. (6879)
Category
Healthcare
Operating Margin for TCI GENE Inc. (6879)
Operating Margin as of November 2026 TTM: 11.62%
According to TCI GENE Inc.'s latest financial reports, its current operating margin (TTM) is 11.62%. At the end of 2025 the company had an operating margin of 7.65%.
Operating Margin history for TCI GENE Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 11.62% | 51.90% |
| 2025 | 7.65% | -49.37% |
| 2024 | 15.11% | 748.88% |
| 2023 | 1.78% | -91.67% |
| 2022 | 21.36% | -18.72% |
| 2021 | 26.28% | 8.91% |
| 2020 | 24.13% | -16.51% |
| 2019 | 28.90% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -96.68% |
US
|
|
| -149.01% | -112.82% |
US
|
|
| 25.57% | -97.80% |
AU
|
|
| 31.23% | -97.31% |
BE
|
|
| 29.35% | -97.47% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TCI GENE Inc.'s operating margin
What is TCI GENE Inc.'s operating margin?
TCI GENE Inc.'s operating margin is 11.62%, as of Nov 2026.
What was TCI GENE Inc.'s operating margin in 2025?
In 2025, TCI GENE Inc.'s operating margin was 7.65%, compared with 15.11% in 2024.
How has TCI GENE Inc.'s operating margin changed since 2020?
From 2020 to 2025, TCI GENE Inc.'s operating margin was highest in 2021 (26.28%) and lowest in 2023 (1.78%).
How does TCI GENE Inc.'s operating margin compare with similar companies?
TCI GENE Inc.'s operating margin (11.62%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.